Business Description
Viridian Therapeutics is a biopharmaceutical company focused on developing medicines for rare and serious conditions, with a particular emphasis on thyroid eye disease and Graves' disease. The company is advancing several drug candidates that work by blocking specific proteins involved in these conditions, including treatments given by injection under the skin as well as through a vein. Founded in 2010 and based in Waltham, Massachusetts, the company rebranded from Miragen Therapeutics in 2021.
